← Back to Search

Legume

Split pea muffins for Post-meal Blood Sugar Response (PEA3 Trial)

N/A
Waitlist Available
Led By Heather Blewett, PhD
Research Sponsored by St. Boniface Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 120 min
Awards & highlights

PEA3 Trial Summary

This trial is testing the effects of different types of peas on blood sugar and appetite in healthy people.

Who is the study for?
Healthy men and women aged 18-40, with a BMI of 18.5-30, who eat three meals daily can join this study on peas in muffins affecting blood sugar and fullness. Excluded are those with diabetes, abnormal cholesterol or triglycerides, recent major surgery, liver/kidney disease, cancer treatment within a year, shift workers, unstable weight or dieting individuals.Check my eligibility
What is being tested?
The trial is testing how different types of muffins (split pea muffins vs wheat muffins vs whole pea muffins) affect post-meal blood sugar levels and feelings of fullness in healthy volunteers as part of research on the physical effects of peas.See study design
What are the potential side effects?
Since the interventions involve eating different types of muffins made from peas or wheat which are common foods, no significant side effects are expected beyond potential mild digestive discomfort for some individuals.

PEA3 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~120 min
This trial's timeline: 3 weeks for screening, Varies for treatment, and 120 min for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-prandial glucose response
Post-prandial insulin
Secondary outcome measures
Appetite ratings
Other outcome measures
Acceptability of test products
Gastrointestinal side effects
Metabolomics
+1 more

PEA3 Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: whole yellow peaExperimental Treatment1 Intervention
2 muffins containing 25g available carbohydrate from whole yellow peas. Intervention: Whole pea muffins
Group II: split yellow peaExperimental Treatment1 Intervention
2 muffins containing 25g available carbohydrate from split yellow peas. Intervention: Split pea muffins
Group III: wheat-satietyPlacebo Group1 Intervention
2 muffins containing wheat flour to match the calories in the whole and split pea muffins. Intervention: Wheat muffins
Group IV: wheat-PPGRPlacebo Group1 Intervention
2 muffins containing 25g available carbohydrate from wheat flour. Intervention: Wheat muffins

Find a Location

Who is running the clinical trial?

University of ManitobaOTHER
595 Previous Clinical Trials
199,498 Total Patients Enrolled
St. Boniface HospitalLead Sponsor
51 Previous Clinical Trials
11,585 Total Patients Enrolled
Agriculture and Agri-Food CanadaOTHER_GOV
33 Previous Clinical Trials
2,281 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor accepting new participants at present?

"According to clinicaltrials.gov's records, this medical trial has stopped its patient recruitment process. The initial posting of the study was on November 7th 2017 and it underwent an update at October 24th 2022. However, there are 9 other trials actively searching for participants as of now."

Answered by AI

Is this study accessible to individuals aged seventy and above?

"The age range of participants eligible to enrol in this trial spans from 18 years old to 40. For minors and seniors, there are separate clinical trials with bespoke inclusion criteria."

Answered by AI

What criteria must potential participants meet to be eligible for this research endeavor?

"This investigation requires 24 participants who present with post-prandial glycaemic response. Eligibility criteria include, but are not limited to: Being a male or female in the 18 - 40 age range; Having a BMI between 18.5 and 30.0 kg/m2; Consuming breakfast, lunch and dinner at typical times; Willingness to sign an informed consent form and comply with all study protocols."

Answered by AI
~3 spots leftby Apr 2025